A groundbreaking discovery has shed light on a crucial enzyme's role in protecting the eustachian tube from damage caused by bacterial infections. This revelation could revolutionize our understanding of middle-ear infections and potentially lead to innovative treatment strategies.
The Battle Against Middle-Ear Infections
Middle-ear infections, particularly those caused by Gram-negative bacteria, continue to be a prevalent health concern worldwide, especially among children. When the eustachian tube, responsible for maintaining pressure balance and clearing mucus, malfunctions during an infection, it can lead to persistent inflammation and increase the risk of chronic otitis media.
To model this inflammatory injury, researchers often use lipopolysaccharide (LPS), a major component of bacteria. Meanwhile, SIRT3, a mitochondrial regulator involved in energy balance and inflammation control, has demonstrated protective effects in various organs, including the lungs, kidneys, heart, and nervous system. However, its role in the middle ear has remained largely unexplored.
Unveiling the Protective Role of SIRT3
Researchers from Tongji Medical College and collaborating hospitals have published a groundbreaking study in the Journal of Otology (November 2025), revealing that a deficiency in SIRT3 significantly exacerbates eustachian tube dysfunction following LPS-induced acute otitis media in mice. Through advanced imaging techniques, mucus analysis, and pressure regulation assessments, the team uncovered how the absence of SIRT3 renders the tissue more vulnerable, leading to thicker mucus, weakened cilia, and impaired tube opening.
The results provide valuable insights into how mitochondrial resilience influences the progression and severity of middle-ear infections. To understand the impact of SIRT3 on inflammatory responses in the ear, the researchers compared wild-type and SIRT3-knockout mice after injecting LPS into the middle ear.
Under baseline conditions, both groups exhibited similar eustachian tube structures. However, once inflammation was triggered, their responses diverged dramatically. Histological and immunohistochemical analyses revealed that SIRT3-deficient mice experienced far more goblet-cell proliferation, resulting in abundant mucus plugs and a significant increase in MUC5AC expression, which is associated with denser and more adhesive mucus.
Scanning electron microscopy further highlighted the pronounced shortening and loss of epithelial cilia, suggesting a weakened mucociliary transport capacity. Functional measurements supported these structural findings, with SIRT3-knockout mice displaying a markedly higher passive opening pressure, indicating increased resistance to tube opening.
While neither SIRT3 deficiency nor LPS alone caused a substantial drop in mucociliary clearance, the combination resulted in a significant decline in transport distance. Additionally, the ability to actively clear negative pressure was reduced in SIRT3-knockout mice under baseline conditions, suggesting that SIRT3 contributes to maintaining mechanical responsiveness.
The Impact of SIRT3 Deficiency
The collective results paint a clear picture: without SIRT3, the eustachian tube becomes significantly more susceptible to inflammatory overload, leading to thickened mucus, deteriorated cilia, and failed pressure regulation mechanisms.
The research team emphasized the complexity of the eustachian tube's function, which relies on a delicate balance of mucus properties, ciliary motion, and pressure-balancing mechanics. Their findings highlight SIRT3 as a stabilizing force during inflammation, and its absence disrupts the system's resilience, leading to heavier mucus, slower clearance, and more difficult pressure equalization.
Understanding this protective role provides valuable insights into why certain individuals are more prone to chronic or recurrent ear infections and could guide the development of new therapeutic approaches.
Therapeutic Implications
The discovery that SIRT3 governs mucus secretion, ciliary integrity, and pressure regulation opens up new avenues for treating eustachian tube dysfunction and preventing chronic otitis media. Enhancing SIRT3 activity or targeting its downstream protective pathways may help restore mucociliary function, reduce mucus obstruction, and accelerate recovery from infection-driven inflammation.
Furthermore, as excessive MUC5AC production and ciliary impairment are also observed in respiratory diseases, these insights could extend beyond otology and contribute to broader airway research. Ultimately, therapies that strengthen mitochondrial resilience have the potential to reshape clinical approaches to persistent middle-ear and airway conditions.
This research was supported by the National Natural Science Foundation of China (Grant NO. 82071057, 82101229) and the National Key Research and Development Program of China (Grant NO. 2023YFC2508001).
The Journal of Otology, an open-access, peer-reviewed journal, welcomes submissions from all disciplines related to both clinical and basic science aspects of the auditory and vestibular system and ear diseases. It aims to improve our understanding of the mechanisms underlying problems of basic or clinical significance and the treatment of patients with auditory and vestibular system disorders.
